¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Overlapping malignant melanoma of skin"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® malignant melanoma ÇÑ±Û ¾Ç¼ºÈæ»öÁ¾
¼³¸í   
  ÇǺο¡¼­ »ý±â´Â ¾ÏÀÇ ÀÏÁ¾. ÁַΠ¹éÀο¡°Ô È£¹ßÇϸç, 50´ë~70´ë¿¡ ¸¹ÀÌ ¹ß»ýÇϰí, ÀþÀº ¿©¼º¿¡°Ô Áõ°¡Çϴ °æÇâÀÌ ÀÖÀ¸¸ç, ÇǺξÏÁß 1~3%¸¦ Â÷ÁöÇϴ µå¹® º´À¸·Î ÇǺο͠±âŸ ±â°üÀÇ ¸á¶ó´Ñ ¼¼Æ÷°è¿¡¼­ À¯·¡Çϴ ¾Ç¼ºÁ¾¾çÀÌ´Ù.
  
  ¿øÀÎÀ¸·Î Àϱ¤³ëÃâ°ú Á÷Á¢ÀûÀΠ°ü°è°¡ ÀÖÀ¸¸ç °¡Á·Àû ¹ß»ýµµ º¼ ¼ö ÀÖ´Ù.
¿µ¹® malignant tumor ÇÑ±Û ¾Ç¼ºÁ¾¾ç
¼³¸í   
  Á¤»óÀûÀΠÁ¶Á÷ ¼¼Æ÷°¡ °¢Á¾ ¹°¸®Àû-È­ÇÐÀû-»ý¹°ÇÐÀûÀΠ¹ß¾Ï ¹°ÁúÀÇ Àۿ렶Ǵ ¿äÀο¡ ÀÇÇØ µ¹¿¬º¯À̸¦ ÀÏÀ¸ÄѼ­ Çü¼ºµÇ´Â Á¾¾ç. ¹«Á¦ÇÑÀÇ ¼¼Æ÷ºÐ¿­·Î ¸Å¿ì ¿Õ¼ºÇϰԠÁõ½ÄÇÏ¿© ÁÖÀ§Á¶Á÷À» ÆÄ±«-ħ½ÄÇÑ´Ù. ¶Ç ¾î¶² È­Çй°ÁúÀ» ³»¾î ÁÖÀ§ÀÇ Á¶Á÷¼¼Æ÷¸¦ Ä§ÇØÇÒ »Ó¸¸ ¾Æ´Ï¶ó, Ç÷°ü ¹× ¸²ÇÁ°üÀ» µû¶ó ÀüÀÌÇÏ¿© Àü½ÅÀÇ Ä«ÄʽþƸ¦ÀÏÀ¸ÄÑ Á×À½À» ÃÊ·¡ÇÑ´Ù. »óÇǼºÀΠ°ÍÀ» ¾ÏÁ¾À̶ó Çϰí, ºñ»óÇǼºÀΠ°ÍÀ» À°Á¾À̶ó ÇÑ´Ù.
¿µ¹® basal layer of skin ÇÑ±Û ±âÀúÃþ
¼³¸í   
  Ç¥ÇÇÀÇ °¡À堾Ʒ¡ ºÎºÐÀ̸砼¼Æ÷ÀÇ ¸ð¾çÀÌ ºñ±³Àû Á÷»ç°¢Çü¿¡ °¡±õ°í ÀÏÁ¤ÇÑ ¹è¿­À» ÇÑ´Ù.
¿µ¹® skin tag ÇÑ±Û ÁãÁ¥, ÇǺο¬¼º¼¶À¯Á¾
¼³¸í   
  ÁַΠ¸ñ, °Üµå¶ûÀÌ, ´Ù¸®¿¡ »ý±â´Â »ì»ö ¶Ç´Â °ú»ö¼Ò Ä§Âø¼ºÀÇ ÀÛÀº ¸ñÀ» °¡Áø ¼¶À¯¼º µ¹Ãâ¹°·Î ´ë°³ ¹«Áõ»óÀÌ´Ù.
¿µ¹® skin ÇÑ±Û ÇǺÎ
¼³¸í   
  ½Åü¸¦ ½Î°í Àִ ¹Ù±ùÃþÀ¸·Î¼­ Ç¥ÇÇ, ÁøÇÇ, ÇÇÇÏÁ¶Á÷À¸·Î ±¸¼ºµÇ¸ç, ¿ÜºÎ È¯°æÀ¸·ÎºÎÅÍ ½Åü¸¦ º¸È£Çϰí Ã¼¿ÂÀ» Á¶ÀýÇϴ ±â´ÉÀ» °¡Áü.
  
  1.Ç¥ÇÇ: ÇǺÎÀÇ °¡Àå ¹Ù±ùÃþÀ¸·Î¼­ ¿Ü¹è¿±¿¡¼­ ±â¿øÇϸ砰¢ÁúÀ̶ó´Â ±¸Á¶ ´Ü¹éÁúÀ» »ý»êÇϴ ±â´ÉÀ» °¡Áü. 4°¡ÁöÀÇ ¼¼Æ÷°¡ Àִµ¥, °¢Áú¼¼Æ÷, ¸á¶ó´Ñ¼¼Æ÷, Langerhans ¼¼Æ÷, ºÎÁ¤Çü ¼¼Æ÷, Merkel¼¼Æ÷°¡ ÀÖ´Ù.
  
  Ç¥ÇÇ¿¡´Â ÀÌ 4°¡Áö ¼¼Æ÷¿Ü¿¡ ´ÙÀ½°ú °°Àº Ç¥ÇÇ ºÎ¼Ó±â°¡ ÀÖ´Ù.
  
  ¿¡Å©¸° ¶¡»ù(eccrine sweat gland): Á¡¸· ÇǺΠ°æ°è ºÎÀ§ µî Æ¯¼öÇÑ ºÎÀ§¸¦ Á¦¿ÜÇÑ ¸ðµç ÇǺο¡¼­ ¹ß°ßµÇ¸ç ¶¡À» ºÐºñÇϴ »ùÀ¸·Î¼­ ½Åü ¿­ Á¶Àý Ã¼°èÀÇ Áß¿äÇÑ ¿ä¼Ò.
  
  ¾ÆÆ÷Å©¸°»ù(apocrine gland): °Üµå¶ûÀÌ, Á¥²ÉÆÇ, Ç×¹® »ý½Ä±â ºÎÀ§, ¿ÜÀ̵µ, ´«²¨Ç® µî¿¡¼­¸¸ ¹ß°ßµÇ¸ç ºÐºñ¹°ÀÇ ±â´ÉÀº Àß ¾Ë·ÁÁ® ÀÖÁö ¾ÊÀ¸³ª µ¿¹°¿¡¼­´Â ¹æ¾î ¹× ¼ºÀû ±â´ÉÀÌ ÀÖÀ½.
  
  ÅÐÁÖ¸Ó´Ï(hair follicle): ¼Õ¹Ù´Ú, ¹ß¹Ù´Ú µî Æ¯¼ö ºÎÀ§¸¦ Á¦¿ÜÇÑ ½Åü Àü ºÎÀ§¿¡ ºÐÆ÷Çϸç Àΰ£¿¡¼­ Áß¿äÇÑ »ý¸®Àû ±â´ÉÀº ¾øÀ¸³ª ¼ºÀû ¸Å·ÂÀ» Áö´Ï´Â ½Åü Àå½ÄÀÇ ±â´ÉÀ» °¡Áü.
  
  ±â¸§»ù(sebaceous gland): ¼Õ¹Ù´Ú°ú ¹ß¹Ù´ÚÀ» Á¦¿ÜÇÑ Àü ÇǺο¡ ºÐÆ÷Çϸ砺кñ¹°À» ±â¸§(sebum)¶ó ºÎ¸§. ³²¼º È£¸£¸óÀÇ Àڱؿ¡ ÀÇÇØ ¼ºÀåÇϸ砻ý¸®Àû ±â´ÉÀº Àß ¾Ë·ÁÁ® ÀÖÁö ¾ÊÀ½.
  
  ¼Õ¹ßÅé(nail)
  
  2. ÁøÇÇ: Ç¥ÇÇ ¾Æ·¡¿¡ Á¸ÀçÇϴ Á߹迱 ±â¿øÀÇ Á¶Á÷À¸·Î¼­ Ç÷°ü, ¸²ÇÁ°ü, ½Å°æ, ±ÙÀ°, Ç¥ÇÇ ºÎ¼Ó±â µîÀ» Æ÷ÇÔÇϰí ÀÖÀ½. Ç¥ÇÇ ¹Ù·Î ¹ØÀÇ ºÎÀ§¸¦ À¯µÎ ÁøÇǶó ÇÏ°í ¾Æ·¡ÃþÀ» ¸Á»ó ÁøÇǶó ÇÑ´Ù. Á¶Á÷ ¼¶À¯¿¡´Â ¾Æ±³Áú ¼¶À¯, ±×¹° ¼¶À¯, Åº·Â ¼¶À¯ÀÇ ¼¼ Á¾·ù°¡ ÀÖ´Ù.
  
  3. ÇÇÇÏ Á¶Á÷: ÁøÇÇ ¾Æ·¡¿¡ Á¸ÀçÇϸç Á߹迱 ±â¿øÀ¸·Î¼­ º¸¿Â ÀÛ¿ë, Ãæ°Ý Èí¼ö ÀÛ¿ë, ¿µ¾ç ÀúÀå ÀÛ¿ëÀÇ ±â´ÉÀÌ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • choroidal malignant melanoma
    ¸Æ¶ô¸·¾Ç¼ºÈæ»öÁ¾
  • malignant melanoma
    ¾Ç¼ºÈæ»öÁ¾
  • overlapping reading frame
    Áߺ¹Çص¶Æ²
  • acral lentiginous melanoma
    ¸»´ÜÈæÀÚÈæ»öÁ¾
  • benign juvenile melanoma
    ¾ç¼º¼Ò¾ÆÈæ»öÁ¾
  • desmoplastic melanoma
    ¼¶À¯Á¶Á÷Çü¼ºÈæ»öÁ¾
  • melanoma
    Èæ»öÁ¾, ¸á¶ó´ÑÁ¾
  • superficial spreading melanoma
    ¾èÀºÈ®»êÈæ»öÁ¾, Ç¥ÀçÈ®»êÈæ»öÁ¾
  • verrucous melanoma
    »ç¸¶±Í¸ð¾çÈæ»öÁ¾
  • malignant
    ¾Ç¼º-
  • malignant anemia
    ¾Ç¼ººóÇ÷
  • malignant carcinoid
    ¾Ç¼ºÄ«¸£½Ã³ëÀ̵å, ¾Ç¼ºÀ¯¾ÏÁ¾
  • malignant change
    ¾Ç¼ºº¯È­
  • malignant cholera
    ¾Ç¼ºÄÝ·¹¶ó
  • malignant degeneration
    ¾Ç¼ºº¯¼º
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • malignant melanoma
    ¾Ç¼ºÈæ»öÁ¾
  • melanoma
    Èæ»öÁ¾, ¸á¶ó´ÑÁ¾
  • malignant
    ¾Ç¼º-
  • malignant mesothelioma
    ¾Ç¼ºÁßÇÇÁ¾
  • neuroleptic malignant syndrome
    Ç×Á¤½Åº´¾à¹°¾Ç¼ºÁõÈıº
  • malignant tumor
    ¾Ç¼ºÁ¾¾ç
  • malignant transformation
    ¾Ç¼º¼¼Æ÷Àüȯ
  • skin care
    ÇǺΰü¸®
  • skin dose
    ÇǺμ±·®
  • skin flare
    ÇǺιßÀû
  • skin fold
    ÇǺÎÁÖ¸§
  • skin friction
    ÇǺθ¶Âû
  • skin flap
    ÇÇºÎÆÇ
  • split-skin graft
    ºÎºÐÃþÇǺÎÀ̽Ä
  • skin line
    ÇǺμ±
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • malignant melanoma
    ¾Ç¼ºÈæ»öÁ¾
  • overlapping reading frame
    Áߺ¹Çص¶Æ²
  • acral lentiginous melanoma
    ¸»´ÜÈæÀÚÈæ»öÁ¾
  • balloon cell melanoma
    dz¼±¼¼Æ÷Èæ»öÁ¾
  • benign juvenile melanoma
    ¾ç¼º¿¬¼ÒÈæ»öÁ¾
  • desmoplastic melanoma
    °áÇÕÁ¶Á÷Çü¼ºÈæ»öÁ¾
  • leptomeningeal melanoma
    ¿¬¼ö¸·Èæ»öÁ¾
  • melanoma
    Èæ»öÁ¾, ¸á¶ó´ÑÁ¾
  • nevocytic melanoma
    ¸ð¹Ý¼¼Æ÷Èæ»öÁ¾
  • nonpigmented melanoma
    ¹«»ö¼ÒÈæ»öÁ¾
  • superficial spreading melanoma
    ¾èÀºÈ®»ê¾Ç¼ºÈæ»öÁ¾
  • verrucous melanoma
    »ç¸¶±Í¾Ç¼ºÈæ»öÁ¾
  • malignant anemia
    (¢¡pernicious anemia) ¾Ç¼ººóÇ÷
  • borderline malignant epithelial ovarian neoplasm
    °æ°è¾Ç¼º»óÇdz­¼ÒÁ¾¾ç
  • malignant carcinoid
    ¾Ç¼ºÄ«¸£½Ã³ëÀ̵å, ¾Ç¼ºÀ¯¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • MOTSA (multiple overlapping thin-slab acquisition)
    ´ÙÁß Áߺ¹ ¼¼ÆíÆÇ ȹµæ
  • acral lentiginous melanoma in situ
    ¿øÀ§Ä¡ ¸»´Ü ÈæÀÚ¼ºÈæ»öÁ¾
  • heritable melanoma syndrome
    À¯Àü¼ºÈæ»öÁ¾ÁõÈıº
  • Hodgkin s disease =malignant lymphoma
    È£ÁîŲº´.
  • Hodgkin s disease =malignant lymphoma
    È£ÁîŲº´.
  • granuloma, malignant
    ¾Ç¼ºÀ°¾ÆÁ¾
  • histiocytoma,malignant fibrous
    Á¶Á÷±¸Á¾, ¾Ç¼º ¼¶À¯¼º
  • histiocytosis,malignant
    ¾Ç¼º
  • hypertension,malignant
    ¾Ç¼º(äÂàõ)
  • ESR=£¾electric skin resistance
    ÇǺÎ(ù«Ý±)Àü±â(ï³Ñ¨)ÀúÇ×(î½ù÷).
  • GSR= galvanic skin reflex
    Àü±âÇǺιݻç(ï³Ñ¨ù«Ý±ÚãÞÒ)
  • Granulomatous slack skin
    À°¾ÆÁ¾¼º ÀÌ¿Ï ÇǺÎ
  • Rebucks skin window
    ·¹ºÎÅ© ÇǺÎâ¹®¼¼Æ÷°üÂû¹ý
  • abdominal skin reflex
    º¹ºÎÇǺιݻç(ÜÙÝ»ù«Ý±ÚãÞÒ).
  • allergic skin disease
    ¾Ë·¹¸£±â(¼º)ÇǺΠÁúȯ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • malignant melanoma
    ¾Ç¼ºÈæ»öÁ¾(¡­ýÙßäðþ).
  • malignant melanoma
    ¾Ç¼ºÈæ»öÁ¾(¡­ýÙßäðþ)
  • malignant melanoma
    ¾Ç¼ºÈæ»öÁ¾
  • malignant melanoma
    ¾Ç¼º Èæ»öÁ¾
  • malignant thrombosed melanoma
    ¾Ç¼º Ç÷ÀüÇü¼º Èæ»öÁ¾
  • malignant undifferentiated melanoma
    ¾Ç¼º ¹ÌºÐÈ­ Èæ»öÁ¾
  • metastatic malignant melanoma
    ÀüÀ̼º ¾Ç¼º Èæ»öÁ¾(¡­ç÷àõýÙßäðþ).
  • metastatic malignant melanoma
    ÀüÀ̼º ¾Ç¼º Èæ»öÁ¾(¡­ç÷àõýÙßäðþ)
  • metastatic malignant melanoma
    ÀüÀ̼º ¾Ç¼º Èæ»öÁ¾(¡­ç÷àõýÙßäðþ)
  • multiple overlapping thin slab acquisition (MOTSA)
    ´ÙÁß Áߺ¹ ¼¼ÆíÆÇ ȹµæ
  • overlapping gene
    Áߺ¹À¯ÀüÀÚ
  • overlapping reading frame
    Áߺ¹Çص¶Æ²
  • acral lentiginous melanoma in situ
    ¿øÀ§Ä¡ ¸»´Ü ÈæÀÚ¼ºÈæ»öÁ¾
  • balloon cell melanoma
    dz¼±¼¼Æ÷(ù¦àÏá¬øà)Èæ»öÁ¾(ýÙßäðþ)
  • benign juvenile melanoma
    ¾ç¼º ¿¬¼Ò¼º(åÐàõ æÄá´àõ)Èæ»öÁ¾(ýÙßäðþ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Skin of glans
    ±ÍµÎÇǺÎ
    [¿¾ ¿ë¾î] ±ÍµÎÇǺÎ
  • Skin retinacula
    ÇǺÎÁöÁö¶ì
    [¿¾ ¿ë¾î] ÇǺÎÁö´ë
  • Skin of penis
    À½°æÇǺÎ
    [¿¾ ¿ë¾î] À½°æÇǺÎ
  • Skin of scrotum
    À½³¶ÇǺÎ
    [¿¾ ¿ë¾î] À½³¶ÇǺÎ
  • Skin
    ÇǺÎ
    [¿¾ ¿ë¾î] ÇǺÎ
  • Skin
    ÇǺΠ[»ì°¯]
    [¿¾ ¿ë¾î] ÇǺÎ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • skin snip biopsy
    ÇǺÎÁ¶°¢»ý°Ë
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • overlapping code
    Áßø(ñìôá) ºÎÈ£(ݬûÜ)
  • overlapping gene
    Áßø(ñìôá) À¯ÀüÀÚ(ë¶îîí­)
  • overlapping zone
    Áßø¿ª(ñìôáæ´)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • melanoma
    Èæ»öÁ¾
  • MOTSA [=multiple overlapping thin-slab acquisition]
    ´ÙÁßÁߺ¹¼¼ÆíÆÇȹµæ
  • multiple overlapping thin slab acquisition [=MOTSA]
    ´ÙÁßÁߺ¹¼¼ÆíÆÇȹµæ
  • overlapping
    Áߺ¹
  • malignant
    ¾Ç¼ºÀÇ
  • malignant adenoma
    ¾Ç¼º¼±Á¾
  • malignant cachexia
    ¾Ç¼º¾Ç¾×Áú
  • malignant change
    ¾Ç¼ºº¯È­
  • malignant degeneration
    ¾Ç¼ºÈ­
  • malignant granuloma
    ¾Ç¼ºÀ°¾ÆÁ¾
  • malignant hypertension
    ¾Ç¼º°íÇ÷¾ÐÁõ
  • malignant neoplasm
    ¾Ç¼º½Å»ý¹°
  • malignant polyp
    ¾Ç¼ºÆú¸³
  • malignant tumor
    ¾Ç¼ºÁ¾¾ç
  • onion skin
    ¾çÆÄ²®Áú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MM macromolecule; Maelzels metronome; major medical [insurance]; malignant melanoma; manubrium to malle...
MH malignant histiocytosis; malignant hyperpyrexia; malignant hypertension; malignant hyperthermia; mam...
MHS major histocompatibility system; malignant hyperthermia in swine; malignant hyperthermia syndrome; m...
MOTSA multiple overlapping thin slab acquisition [technique]
CMM cell-mediated mutagenesis; cutaneous malignant melanoma
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CMM Cutaneous malignant melanoma
DMM Desmoplastic Malignant Melanoma
MM Malignant Melanoma
MMM Metastatic malignant melanoma
NMSC Non Melanoma Skin Cancer
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • C43.8
    Overlapping malignant melanoma of skin
    ÇǺΠ¾Ç¼º Èæ»öÁ¾ÀÇ Áߺ¹º´ÅÍ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • malignant melanoma
    ¾Ç¼º Èæ»öÁ¾
    1. ¿ÜÀ½¿¡ »ý±â´Â °¡Àå Áß¿äÇÑ º´º¯ÀÎ Á¾¾çÀÇ ÀÏÁ¾À¸·Î ¿ÜÀ½ÀÇ ¾Ç¼º Èæ»öÁ¾Àº µå¹°°í, ¿©¼º¿¡¼­ °üÂûµÇ´Â Èæ»öÁ¾ÀÇ 2%°¡ ¿ÜÀ½¿¡¼­ ¹ß»ýÇÑ´Ù. 2. »ö¼Ò ¼¼Æ÷¿¡ »ý±ä ¾Ç¼º Á¾¾ç. 3. Ç¥ÇǼº Èæ»ö±¸¿Í ±× Àü±¸Ã¼·ÎºÎÅÍ ¹ß»ýÇÏ´Â ´ë´ÜÈ÷ ¾Ç¼ºÀÎ Á¾¾çÀÌ´Ù. ¸ðµç ¾Ç¼º Á¾¾ç Áß 1%°¡ ¾Ç¼º Èæ»öÁ¾ÀÌ´Ù. ÀÌÁß 90%´Â ¿ÜÇÇ¿¡ ³ªÅ¸³ª°í 10%´Â ÇǺΠ¿Ü¿¡ ³ªÅ¸³­´Ù. ¸ðµç ¾Ç¼º Èæ»öÁ¾ Áß 1%´Â ±¸°­ ³»¿¡¼­ ¹ß»ýÇÑ´Ù. ¹ß»ýÀ²ÀÌ Áõ°¡µÇ´Â °Íó·³ º¸ÀÌ´Â ÀÌ·± Á¾¾çÀÇ Æ¯È÷ ³ª»Û Á¡Àº ¸²ÇÁ ¼øÈ¯°ú Ç÷¾× ¼øÈ¯À» ÅëÇØ ºü¸£°Ô ÀüÀ̵Ǵ °ÍÀÌ´Ù.
  • overlapping
    Áߺ¹
    ºÎºÐÀû Çǰ³¹°ÀÌ ¾î¶² °ÍÀÌ ´Ù¸¥ °Í À§¿¡ »¸Ä¡°Å³ª ºÎºÐÀûÀ¸·Î µ¤´Â °Í.
  • overlapping lesion
    Áߺ¹ º´¼Ò
  • acral lentiginous melanoma
    ¸»´Ü¼º ÈæÁ¡¾ç Èæ»öÁ¾
    1. »óÇdz» Áõ½ÄÇϰí ÀÖ´Â Á¾¾ç ¼¼Æ÷´Â ¾Ç¼º ÈæÀÚÈæ»öÁ¾°ú À¯»çÇÑ ¼Ò°ßÀ̳ª Ç¥ÇÇ Áõ½Ä°ú ¼öÁö»ó µ¹±â¸¦ Áö´Ñ Èæ»öÁ¾ ¼¼Æ÷µéÀÌ ´Ù¼ö °üÂûµÇ´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù. 2. ¼±´ÜºÎ »Ó¸¸ ¾Æ´Ï¶ó ¼Õ¹Ù´Ú, ¹ß¹Ù´Ú ÁÖÀ§ ¹× Á¡¸·¿¡µµ »ý±â¸ç ƯÈ÷ µ¿¾çÀο¡°Ô ºóµµ°¡ ³ô´Ù. ºñ±³Àû Àå±â°£ÀÇ ¹ÝÁ¡ ³»Áö´Â ¼ö §¯³ª µÇ´Â ¹Ý ÇüÅ·Π°üÂûµÇ´Â ºñħÀ±±â¸¦ °¡Áö¸ç ƯÈ÷ ¼Õ°¡¶ôÀ̳ª ¹ß°¡¶ô »çÀÌ¿¡ ¹ß»ýÇÏ´Â °æ¿ì¿¡´Â Àå±â°£ ¹ß°ßµÇÁö ¾Ê°í Áö³ª°¡±âµµ ÇÑ´Ù.
  • benign juvenile melanoma
    ¾ç¼º À¯³â¼º Èæ»öÁ¾
    ¾ç¼º, À¶±â¼ºÀÌ¸ç ´Ü´ÜÇϰí ÇÎÅ©»ö ³»Áö ÀÚÀû»öÀ» ¶í ±¸ÁøÀÌ¸ç ´ë°³ ¾à°£ ³«¼³ ¼³Ç¥¸éÀ» °®°í, ÀϹÝÀûÀ¸·Î ¾ó±¼ ƯÈ÷ »´¿¡ ¹ß»ýÇÏ¸ç »çÃá±â Àü¿¡ ¹ßº´ÇÏ´Â °æ¿ì°¡ ¸¹´Ù.
  • early melanoma
    Ãʱâ Èæ»öÁ¾
    ¸á¶ó´Ñ ¼¼Æ÷ÀÇ ¾Ç¼º Á¾¾ç¿¡ Ãʱ⠴ܰè. Á¾Á¾ ¾ç¼º ¸ð¹ÝÀ¸·Î ¿ÀÇØµÈ´Ù. ±¸°­¿¡¼­ °¡Àå ÈçÇÑ Èæ»öÁ¾Àº Ç¥Ãþ È®À强 Èæ»öÁ¾, °áÀý¼º Èæ»öÁ¾, ¸»´ÜÈæ»öÁ¾À¸·Î ³ª´µ¾îÁø´Ù. ¿¹Èİ¡ ³ª»Ú´Ù.
  • early nodular melanoma
    Ãʱ⠼ҰáÀý¼º Èæ»öÁ¾
  • heritable melanoma syndrome
    À¯Àü¼º Èæ»öÁ¾ ÁõÈıº
  • juvenile melanoma
    ¿¬¼Ò¼º Èæ»öÁ¾
  • lentigo maligna melanoma
    ¾Ç¼º Èæ»öÁ¾
    ¸á¶ó´Ñ ¼¼Æ÷¿¡¼­ À¯·¡µÈ ¾Ç¼º Á¾¾ç. ¼öÆò Áõ½Ä±âÀÇ Èæ»öÁ¾ÀÎ ¾à¼º ÈæÀÚÀÇ ¼öÁ÷ Áõ½Ä±â¿¡ ÇØ´çÇÑ´Ù. ¼öÆò Áõ½Ä±âÀÇ Èæ»öÁ¾À¸·Î¼­ Ư¡ÀûÀ¸·Î Á߳⠳»Áö ³ë³âÃþÀÇ ÇÞºµÀ» ¸¹ÀÌ ¹ÞÀº ¾Èº¯ºÎ¿¡ È£¹ßÇÑ´Ù.
  • malignany melanoma
    ¾Ç¼º Èæ»öÁ¾
  • melanoma
    Èæ»öÁ¾
    1. ÇǺγª ´Ù¸¥ ±â°üÀÇ melanocytic system¿¡¼­ »ý±ä Á¾¾ç. ÀÌ ¿ë¾î°¡ ´Üµ¶À¸·Î »ç¿ëµÉ ¶§´Â ¾Ç¼º Èæ»öÁ¾À» ÀÏÄ´´Ù. 2. ÇǺÎÀÇ ¾Ç¼º, ¾îµÎ¿î Âø»ö Á¡ ¶Ç´Â Á¾¾ç. ÇÇºÎ Èæ»öÁ¾ÀÇ 4°¡Áö Á¾·ù´Â Ç¥Àç È®»ê¼º Èæ»öÁ¾, ¾Ç¼º Èæ»öÁ¾, ¸»´Ü Èæ»öÁ¾, °áÀý¼º Èæ»öÁ¾ÀÌ´Ù. À̵é Áß Ã³À½ 3°¡Áö´Â Ç¥À缺À¸·Î ¼ºÀåÇÏ¸ç ¹æ»ç»óÀ¸·Î È®ÀåÇÏ´Â °æÇâÀÌ ÀÖÀ¸¸ç ±íÀÌ Ä§ÅõÇÏÁö´Â ¾Ê´Â´Ù. °áÀý¼º Èæ»öÁ¾Àº ±íÀÌ Ä§ÅõÇϸç ÀüÀ̵ȴÙ. ¾Ç¼º Èæ»öÁ¾Àº 1995³â ¹Ì±¹¿¡¼­ 7,200¸íÀÇ »ç¸Á ¿øÀÎÀ̾ú´Ù.
  • melanoma in situ
    »óÇdz» Èæ»öÁ¾
  • superficially spreading melanoma
    ÆÛÁ®³ª°¡´Â Ç¥À缺 Èæ»öÁ¾
  • borderline malignant epithelial ovarian neoplasms
    °æ°è¼º »óÇǼº ³­¼Ò Á¾¾ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
cancer, malignant melanoma A skin cancer that begins in cells called melanocytes that can grow together to form benign (not cancerous) moles. A change in size, shape, or colour of a mole can be a sign of melanoma. Melanoma can be cured if detected early, before spread (metastasis) to other areas of the body. Diagnosis is confirmed with a biopsy of the abnormal skin. Sun exposure can cause skin damage that can lead to melanoma.
(12 Dec 1998)
malignant lentigo melanoma <tumour> A melanoma arising from a malignant lentigo.
(05 Mar 2000)
malignant melanoma <oncology, tumour> A malignant tumour which arises from the pigment producing cells (melanosomes) of the deeper layers of the skin (or the eye). Melanoma is the leading cause of death attributable to skin lesions. Described as an irregular dark skin lesion that may have areas of varying colour. Often greater than 6 mm in diameter.
(27 Sep 1997)
malignant melanoma: gallium imaging <radiology> Greater than50% sensitivity for primary and metastatic sites: 73% sensitivity if lesion is greater than 2 cm, 17% sensitivity if less than 2 cm, see: gallium: indications malignant melanoma
(12 Dec 1998)
malignant melanoma in situ A melanoma limited to the epidermis and composed of nests of atypical melanocytes and scattered single cells extending into the upper epidermis; local excision is curative although the lesion, if untreated, may soon invade the dermis. Malignant lentigo may be considered a slowly progressive type of malignant melanoma in situ.
(05 Mar 2000)
malignant melanoma: staging <radiology> Clark staging: level I: all tumour cells above basement membrane (in situ), level II: tumour extends to papillary dermis, level III: tumour extends to interface between papillary and reticular dermis, level IV: tumour extends between bundles of collagen of reticular dermis, level V: tumour invasion of sucutaneous tissue (87% metastases) Breslow staging: thin: less than 0.75 mm depth of invasion, intermediate: 0.76 - 3.99 mm depth of invasion, thick: greater than 4 mm depth of invasion see: malignant melanoma
(12 Dec 1998)
desmoplastic malignant melanoma <tumour> A melanoma with marked fibrosis surrounding atypical spindle-shaped melanocytes in the dermis.
(05 Mar 2000)
genes, overlapping Genes whose nucleotide sequences overlap to some degree. The overlapped sequences may involve structural or regulatory genes of eukaryotic or prokaryotic cells.
(12 Dec 1998)
overlapping <cell biology> In cell locomotion situation in which the leading lamella of one cell moves actively over the dorsal surface of another cell should be distinguished from underlapping.
(18 Nov 1997)
overlapping gene <molecular biology> Different genes whose nucleotide coding sequences overlap to some extent. The common nucleotide sequence is read in two or three different reading frames thus specifying different polypeptides.
(18 Nov 1997)
overlapping reading frame <molecular biology> Start codons in different reading frames which generate different polypeptides from the same DNA sequence.
(09 Oct 1997)
acral lentiginous melanoma <tumour> A form of malignant lentigo melanoma that occurs in acral areas not excessively exposed to sunlight and where hair follicles are absent.
(05 Mar 2000)
amelanotic melanoma <tumour> An anaplastic melanoma consisting of cells derived from melanocytes but not forming melanin.
(05 Mar 2000)
benign juvenile melanoma A benign, slightly pigmented or red superficial small skin tumour composed of spindle-shaped, epithelioid, and multinucleated cells that may appear atypical; most common in children, but also appearing in adults.
Synonym: benign juvenile melanoma, epithelioid cell nevus, spindle cell nevus.
(05 Mar 2000)
cancer, melanoma A skin cancer that begins in cells called melanocytes that can grow together to form benign (not cancerous) moles. A change in size, shape, or colour of a mole can be a sign of melanoma. It can be cured if detected early, before spread (metastasis) to other areas. Diagnosis is confirmed by a biopsy of the abnormal skin. Sun exposure can cause skin damage that can lead to melanoma.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • malignant melanoma
    ¾Ç¼º Èæ»öÁ¾
  • melanoma
    Èæ»öÁ¾
  • malignant
    ¾ÇÀǸ¦ ǰÀº; ¾Ç¼ºÀÇ; ¹ÝÇ×ÀÚ
  • malignant
    À¯ÇØÇÑ;¾Ç¼ºÀÇ;¾ÇÀǸ¦ ǰÀº;... (¿µ»ç) Charles I ½Ã´ëÀÇ ¿Õ´ç¿ø
  • skin
    ÇǺÎ
  • galvanic skin response
    Àü±â ÇǺΠ¹ÝÀÀ(°ÅÁþ¸» ŽÁö±â¿¡ ÀÀ¿ë)
  • goldbeater's skin
    ±Ý¹Ú°øÀÇ °¡Á×(¹Ú »çÀÌ¿¡ ³¢¿ì´Â)
  • skin
    ÇǺÎ;°¡Á× Á¦Ç°;°¡Á×;±¸µÎ¼è;»ç±â²Û;°¡Á×(²®Áú)À» ¹þ±â´Ù;»ì°¡Á×ÀÌ ¹þ¾îÁö°Ô ÇÏ´Ù;°¡Á×À¸·Î µ¤´Ù;»çÃëÇÏ´Ù;¼ÓÀÌ´Ù;be in a person's ~ ¾Æ¹«ÀÇÀÔÀåÀÌ(óÁö°¡)µÇ´Ù;by(with)the ~ of one's teeth °¡±î½º·Î;°£½ÅÈ÷
  • skin diving
    ½ºÅ²´ÙÀ̺ù
  • skin effect
    (Á֯ļö ÀüµµÃ¼ÀÇ)Ç¥ÇÇ È¿°ú
  • skin flick
    Æ÷¸£³ë ¿µÈ­
  • skin food
    Å©¸²·ù;¹Ì¾È¼ö
  • skin game
    »ç±â;ÇùÀâ
  • skin grafting
    ÇǺΠÀ̽Ä(¼ú) 
  • skin test
    ÇǺΠ½ÃÇè
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á